How Does Quality Control Reduce Risks in Pharmaceutical Intermediate Supply?

2026-08-14

1. Why Does Impurity Profiling Minimize Downstream Drug Failure?

In our factory, we have seen that unknown impurities are the number one cause of API manufacturing failures. A pharmaceutical Intermediate may contain organic impurities, residual solvents, or genotoxic impurities that are not detected by simple purity tests. Our quality control system includes a comprehensive impurity profiling using HPLC with diode array detection and LC-MS. We identify all peaks above 0.05 percent and characterize them. For example, a recent batch of our Intermediates for an antihypertensive drug contained a trace isomer that could have caused side effects if not removed. Our QC team flagged it, and we modified the crystallization step to eliminate it. This level of scrutiny is what reduces the risk of a costly API batch rejection. Our Sandoo Pharmaceuticals and Chemicals Co.,Ltd. also performs forced degradation studies to understand the impurity formation pathways. This allows us to set specifications that are practical and protective. By controlling impurities at the Intermediate stage, we prevent problems from escalating further down the supply chain.

2. How Does Incoming Raw Material Testing Prevent Batch Contamination?

An Intermediate is only as good as the starting materials. Our QC program begins with rigorous testing of every incoming raw material, including solvents, reagents, and catalysts. We test for identity, purity, and water content. For example, we once received a shipment of solvent that was contaminated with a stabilizer not listed on the certificate. Our GC analysis detected it, and we rejected the shipment. This prevented a potential reaction failure in the pilot plant. Our factory uses a risk based approach: critical raw materials are tested 100 percent, while less critical ones are tested on a skip lot basis. The table below summarizes our incoming material testing criteria.

Raw material type	Test parameters	Acceptance criteria	Frequency
Key starting materials (e.g., chiral amines)	Assay, enantiomeric purity, water, residual solvents	Assay ≥ 98%, e.e. ≥ 99%	Each batch
Solvents (e.g., ethyl acetate)	GC purity, water, non volatile residue	Purity ≥ 99.5%, water ≤ 0.05%	Each batch
Catalysts (e.g., palladium on carbon)	Metal content, activity test	5% Pd ± 0.2%, activity pass	Each batch
General reagents (salts, acids)	Purity by titration, heavy metals	As per specification sheet	Skip lot (1 in 5)

QC test type	Application	Risk reduced
GC residual solvent	Detects leftover reaction solvents	API toxicity, solvent flammability
ICP-MS heavy metals	Measures Pd, Pt, etc.	Heavy metal contamination in final drug
TOC (Total Organic Carbon)	Cleanliness of process equipment	Cross contamination between batches
FTIR	Identity confirmation of Intermediates	Wrong compound sent to customer

Our Sandoo has a dedicated raw material quarantine area. No material enters production without a QC release. This has eliminated all contamination incidents in the past 8 years.

3. How Does In Process Control Ensure Batch to Batch Consistency?

Even if raw materials are pure, the reaction conditions must be controlled. Our QC team monitors critical process parameters such as temperature, pH, pressure, and reaction time. We use in situ probes for pH and temperature, and we sample the reaction mixture at key milestones to check conversion by TLC or HPLC. This real time monitoring allows us to stop a batch if it deviates from the proven range, rather than finding out after work up. For example, during a nitration step, the temperature rose by 2°C above the validated range. Our automated system alerted the operator, who adjusted the cooling. The batch continued and met all specifications. Without this in process control, the batch might have produced a different isomer. Our factory also conducts a process verification test every 6 months to ensure the equipment and operators are performing as validated.

4. How Does Stability Testing Mitigate Supply Chain Delays?

An Intermediate may be stored for weeks or months before being used in API synthesis. If it degrades during storage, the customer's timeline is disrupted. Our QC program includes a stability study protocol that tests our Intermediates under ICH conditions for 12 to 24 months. We test for purity, water content, and appearance at regular intervals. We also conduct accelerated stability tests at 40°C and 75 percent relative humidity to predict shelf life. For a recent Intermediate, we found that it was sensitive to moisture and required a desiccant in the packaging. We added this recommendation to our technical data sheet. This has prevented customer complaints about caking or hydrolysis. Our Sandoo provides a retest date with every shipment, based on real data. This allows our customers to plan their production schedules with confidence, knowing the Intermediates will perform as expected.

Frequently Asked Questions About Quality Control for Pharmaceutical Intermediates

Question 1: What is the difference between quality control and quality assurance in Intermediate supply?

Answer: Quality control (QC) is the set of testing activities that verify the product meets specifications. This includes sampling, analysis, and release of the Intermediates. Quality assurance (QA) is the broader system that ensures the entire manufacturing process is designed and operated correctly. QA sets the procedures, audits the QC lab, and manages change control. In our factory, QC is the laboratory function, while QA is the management oversight. Both are essential for reducing risk. For example, QC may detect a high level of a specified impurity, but QA investigates the root cause and implements corrective action to prevent recurrence. A professional supplier must have both functions clearly defined. Our Sandoo Pharmaceuticals and Chemicals Co.,Ltd. has separate QC and QA departments, which is a requirement for GMP compliance.

Question 2: How often should a supplier revalidate their analytical methods for Intermediates?

Answer: Analytical methods should be revalidated whenever there is a change in the process, raw material source, or equipment. At a minimum, we recommend a full revalidation every two years, as required by ICH Q2. For critical methods, such as chiral purity determination, we perform a shorter revalidation annually. Our factory also revalidates after any major instrument repair or software upgrade. The revalidation must include specificity, linearity, accuracy, precision, and ruggedness. If these parameters drift, the method may not correctly separate critical impurities. Our QC team maintains a validation schedule for all our Intermediates. This systematic approach ensures that the test results are reliable and defensible during regulatory inspections.

Question 3: Can a customer use the supplier's CoA without performing their own incoming testing?

Answer: This depends on the customer's quality system and the regulatory requirements. In many cases, pharmaceutical companies are required to perform their own identity testing as part of their incoming goods inspection, even if they trust the supplier. This is known as the "skip lot" or "reduced testing" program, which requires a documented history of supplier reliability. Our Sandoo Pharmaceuticals and Chemicals Co.,Ltd. has achieved supplier status where several customers have reduced their testing frequency based on our performance. However, we always recommend that customers conduct at least an identity check (e.g., FTIR) to confirm the material. If the Intermediates are used for clinical trial materials, full testing is usually mandatory. We provide all analytical data to help our customers perform their own testing efficiently.

Final Summary

Quality control is the cornerstone of risk reduction in pharmaceutical Intermediate supply. From impurity profiling and raw material testing to in process monitoring and stability studies, a robust QC system ensures that the Intermediates are safe, effective, and consistent. Our factory has invested heavily in state-of-the-art analytical equipment and trained personnel. This commitment to quality has earned us the trust of leading pharmaceutical companies. Sandoo Pharmaceuticals and Chemicals Co.,Ltd. is dedicated to providing Intermediates that help our customers succeed.

Previous:No News

Next:No News